Avalere Health Redefines Mission Under New Leadership, Focuses on Improving Patient Access to Care

Avalere Health, a prominent biopharma commercialization partner, has announced a significant shift in its corporate strategy and leadership, aiming to address critical healthcare access issues. The company's transformation comes weeks after the appointment of Amar Urhekar as its new CEO, signaling a renewed commitment to patient-centric healthcare solutions.

"Every Patient Possible": A New Strategic Direction

Avalere Health has unveiled its new mission, "Every Patient Possible," which seeks to ensure that "every patient is identified, supported, treated and cared for." This strategic pivot reflects the company's recognition of a persistent gap in healthcare delivery, where scientific and technological advancements have improved outcomes for some but failed to reach many others in need.

Urhekar emphasized the urgency of this new direction, stating, "Too often, people are stuck waiting for the treatment and care they deserve. We have the talent and conviction across the product lifecycle to drive real change for patients everywhere."

Innovative Approaches to Healthcare Access

To support its ambitious goals, Avalere has introduced several key initiatives:

1. SenseMaking Framework: This AI- and data-driven strategic tool aims to unify Avalere's experts in identifying health disparities and developing targeted solutions. The framework is designed to help biopharma partners pinpoint and address barriers to drug access.

2. Rural Health Partnership: Avalere has joined forces with the University of North Carolina's Student Teams Achieving Results (STAR) program to explore novel approaches to supporting individuals in underserved areas. This collaboration targets the estimated 30 million people in North America affected by rural health issues.

Organizational Restructuring for Enhanced Impact

The company's refocused mission follows a period of significant organizational change. Avalere Health took its current form after U.K. agency Fishawack Health acquired the U.S. consulting and advisory firm Avalere in 2022. Urhekar, who initially joined as chief operating officer in 2023, played a pivotal role in realigning the combined entity around its core advisory, medical, and marketing capabilities.

This strategic reorganization underpins Avalere's renewed focus on supporting access to healthcare, with Urhekar at the helm to drive the company's patient-centric vision forward.